Dr. Sruti Chandrasekaran

Senior Consultant

18 Years of Experience

Diabetologist, Endocrinologist

MBBS, MD, Fellowship

Reg. No.:78544, Tamil Nadu Medical Council

English, Hindi

Consultation Fee ₹

Book Appointment

Dr. Sruti Chandrasekaran is a highly skilled Endocrinologist and Diabetologist with 18 years of experience.
Her areas of expertise include the management of pituitary disorders, adrenal disorders, gonadal disorders, osteoporosis, and neuroendocrine disorders.
She specializes in transplant endocrinology and transgender medicine.
She completed her MBBS from Kilpauk Medical College, Chennai, in 2006 and pursued an MD in General Medicine from the State University of New York in 2010.
She is American board-certified in Endocrinology, Diabetology & Metabolism.
She has been part of various research in her field and has authored several articles for renowned journals, both national and international.
She is a member of the American Association Of Clinical Endocrinology, Endocrine Fellow Foundation, and National Lipid Association.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Whatsapp Number *

Query

Best Lady Doctor Award, 2006
Times Health Excellence Award, Excellent Service in Diabetology, 2020
Best Fellow Award, University of Maryland, 2011
Gold medal and Certificate of Merit, Medicine and Rheumatology, Intercollegiate exam, Stanley Medical College and Madras Medical College
Gold medal in physiology, pathology, pediatrics, forensic medicine, and ophthalmology

He has numerous publications. Some of her papers published are:

Santosh, U., Sruti, C., & Kiran, M. (2009). Constrictive pericarditis in a patient with sinus venosus atrial septal defect and anomalous right upper pulmonary venous return. DOAJ (DOAJ: Directory of Open Access Journals).
Kim, J. A., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012). Role of Lipotoxicity in Endothelial Dysfunction. Heart Failure Clinics, 8(4), 589–607.
Munir, K. M., Chandrasekaran, S., Gao, F., & Quon, M. J. (2013). Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Endocrinology and Metabolism/American Journal of Physiology: Endocrinology and Metabolism, 305(6), E679–E686.
Streeten, E. A., Ramirez, S., Eliades, M., Jaimungal, S., Chandrasekaran, S., Kathleen, R., Morton, D. H., Puffenberger, E. G., Herskovitz, R., & Leonard, M. B. (2015). Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure. Bone, 77, 17–23.
Bajaj, S., Makkar, B. M., Abichandani, V. K., Talwalkar, P. G., Saboo, B., Srikanta, S. S., Das, A., Chandrasekaran, S., Krishnan, P. V., Shah, A., Abraham, G., Tikku, P., & Kumar, S. (2016). Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian Journal of Endocrinology and Metabolism, 20(2), 268.